139 search results for: patient burden

The Benefits of Early Intervention in Reducing the <b>Burden</b> of Disease in Children With Atopic Dermatitis
On Demand
The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis

This page presents educational material, infographics, and video highlights from our recent ADVENT symposia, including the 2025 World Congress of Pediatric Dermatology (WCPD) in Buenos Aires, Argentina, exploring the pathophysiology of type 2 inflammation and atopic dermatitis, the burden of disease leading to cumulative life course impairment (CLCI), and the risk of the atopic march in pediatric patients with atopic dermatitis.

ADVENT at WCI
On Demand
Decoding Chronic Itch and More in PN: Implications of Real-World Data for Clinical Practice

Join Professors Matthias Augustin and Sarina Elmariah for an engaging ADVENT symposium as they explore the pivotal role of type 2 inflammation in prurigo nodularis and chronic itch.

Eosinophilic Esophagitis (EoE) Pediatric Interactive <b>Patient</b> Case
Gastroenterology
Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case
interactivity

Experience a pediatric patient's journey from infancy to adolescence with guideline-based learnings on EoE diagnosis, treatment, and long-term care.

View more
Transforming Prurigo Nodularis Care in 2026: New Real-World Evidence for Comprehensive Care and Treatment Optimization
Dermatology
Transforming Prurigo Nodularis Care in 2026: New Real-World Evidence for Comprehensive Care and Treatment Optimization
expert video

Join Drs. Sarina Elmariah and Pedro Bastos to explore the full systemic burden of prurigo nodularis, looking beyond the nodules to discover how real-world evidence for approved biologics can inform treatment decisions and long-term care across diverse patient populations.

View more
ADVENT at EADV 2026
On Demand
Transforming Prurigo Nodularis Care in 2026: New Real-World Evidence for Comprehensive Care and Treatment Optimization

Drs. Sarina Elmariah and Pedro Bastos led an engaging ADVENT Industry Hub at EADV 2026 in Vienna, Austria, exploring the full systemic burden of prurigo nodularis (PN) beyond its visible nodules. The session highlighted how real-world evidence for approved biologics can inform treatment decisions and support long-term disease management across diverse patient populations.

ERS 2025 | Type 2 Severe Asthma "Unplugged": Reducing Mucus to Improve Long-term <b>Patient</b> Outcomes
Pulmonology
ERS 2025 | Type 2 Severe Asthma "Unplugged": Reducing Mucus to Improve Long-term Patient Outcomes
videoanimation

Join leading pulmonologists Drs. Njira Lugogo, Simon Couillard, and Mario Castro, as they explore the role of type 2 inflammation in the pathogenesis of mucus plugging in the airways, the burden of excess mucus in patients with moderate-to-severe asthma, and how reducing airway mucus may lead to improved long-term patient outcomes.

View more
ADVENT On Air | Loss of Smell in CRSwNP <b>Patient</b>s
Rhinology
ADVENT On Air | Loss of Smell in CRSwNP Patients
Podcast

Profs. Wytske Fokkens and Joaquim Mullol discuss the clinical significance of the loss of smell in patients with CRSwNP.

View more
Event Page Thumbnail
Congress
27
April
2026
Congress
ADVENT at CEORL-HNS 2026

Join Sanofi and Regeneron for an educational symposium on type 2 inflammation, patient characteristics predictive of disease recurrence, and emerging real-world evidence for biologics in CRSwNP.